ecrin-mdr-crcClinical2023colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/113472China9ECRIN MDRNot yet recruitingfalseSecond-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102Interventions: experimental group:HR0708035, FU/LV and BP102 Primary outcome(s): Objective response rate Study Design: Single arm2023-09-15113472ChiCTR2300075966